Suppr超能文献

婴儿和儿童死后血清地高辛浓度升高的解读

Interpretation of elevated postmortem serum concentrations of digoxin in infants and children.

作者信息

Koren G, Beatie D, Soldin S, Einerson T R, MacLeod S

机构信息

Division of Clinical Pharmacology, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

Arch Pathol Lab Med. 1989 Jul;113(7):758-61.

PMID:2742457
Abstract

The relationship between excessive postmortem digoxin concentrations (greater than 6.4 nmol/L) and administered dose, and antemortem levels and time of sampling after death were determined in 27 digitalized children who died in our hospital between March 24, 1981 and September 1, 1983. In all 27 cases, postmortem concentrations were higher than antemortem levels (9.5 +/- 2.5 nmol/L and 3.12 +/- 1.72 nmol/L, respectively). In none of these patients was there clinical or electrocardiographic evidence of digitalis toxicity. There was a significant correlation between antemortem and postmortem determinations, and between time of sampling after death and postmortem concentration. Positive correlation existed between antemortem or postmortem concentrations and dose per kilogram. The degree of elevation in digoxin levels was uniform in most cases, and the likelihood of elevation falling in the range 3.5 to 7.0 nmol/L was 66%. If the estimated concentration of digoxin at the time of death was taken as baseline, in 75% of cases the subsequent elevation was between 5.3 and 8.3 nmol/L (mean, 6.5 +/- 1.1 nmol/L). Digoxin concentrations measured in newborn infants not receiving digoxin were significantly higher after death (1.5 +/- 0.3 nmol/L) than in age-matched living infants not receiving digoxin (0.5 +/- 0.3 nmol/L). These data indicate that the size of antemortem dose, the time of sampling after death, and existence of endogenous digoxinlike factors affect postmortem readings of digoxin levels. Consequently, excessive postmortem determinations cannot be directly interpreted as proof of toxic antemortem levels.

摘要

1981年3月24日至1983年9月1日期间,在我院死亡的27例使用过地高辛的儿童中,测定了死后地高辛浓度过高(大于6.4纳摩尔/升)与给药剂量、生前水平及死后采样时间之间的关系。在全部27例病例中,死后浓度均高于生前水平(分别为9.5±2.5纳摩尔/升和3.12±1.72纳摩尔/升)。这些患者均无洋地黄中毒的临床或心电图证据。生前和死后测定值之间、死后采样时间与死后浓度之间存在显著相关性。生前或死后浓度与每千克剂量之间呈正相关。在大多数情况下,地高辛水平升高的程度是一致的,升高幅度在3.5至7.0纳摩尔/升之间的可能性为66%。如果将死亡时地高辛的估计浓度作为基线,75%的病例随后的升高幅度在5.3至8.3纳摩尔/升之间(平均为6.5±1.1纳摩尔/升)。未接受地高辛治疗的新生儿死后测定的地高辛浓度(1.5±0.3纳摩尔/升)显著高于未接受地高辛治疗的年龄匹配的存活婴儿(0.5±0.3纳摩尔/升)。这些数据表明,生前剂量大小、死后采样时间以及内源性地高辛样因子的存在会影响死后地高辛水平的读数。因此,死后过高的测定值不能直接解释为生前中毒水平的证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验